
| 3 min read
Scientists identified stem cells whose dysregulated calcium signaling drives the degenerative condition, opening the door to novel treatments.
| 4 min read
Antibody discovery is becoming less about finding the strongest binder and more about finding molecules that can survive the journey to the clinic.
| 4 min read
A new consortium will characterize 10,000 antibodies to a single standard, aiming to train AI models that flag manufacturing risks before candidates advance.
| 2 min read
In mice, the new drug led to recovery of motor function and vision by protecting nerve fibers and myelin.News
Cancer Research News
Imagene AI's quantitative pathology and CellCarta's CDx infrastructure offer biopharma sponsors one path from AI biomarker assay to regulatory submission
As 3D cell models advance toward mainstream use, the field must learn to work with biological variability rather than against it.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Explore how advances in liquid handling are making automation more accessible, flexible, and practical for modern labs.
Explore how integrated cell-based assays reveal the mechanisms that drive antibody-drug conjugate activity and inform candidate selection.




















